Testing effectiveness (Phase 2)Study completedNCT03698279
What this trial is testing
Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age
Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 665